Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease primarily affecting women, driven by TSC1 or TSC2 mutations that lead to constitutive mTORC1 activation and progressive respiratory failure. The gene discussed is TSC2; the disease is cystic disease of lung.